mRNA expression of TXNDC12 in pan-cancer in TCGA and GTEx database, (B)
(2015) reported results from a Phase 3 clinical trial of afamelanotide in erythropoietic protoporphyria, demonstrating increased time to phototoxicity symptoms and supporting regulatory approval [2]
Emerging Research Suggests Potential Benefits GLP-1 agonists (glucagon-like peptide), such as Mounjaro, Wegovy, and Ozempic, are primarily prescribed for managing type 2 diabetes and obesity
These findings uncover a non-canonical mechanism of action for GLP-1 analogs, highlighting a specific microbiota-endocannabinoid metabolic pathway as a potential therapeutic target for depression.
stata riportata nel 4,9% dei trattati con semaglutide orale 25 mg e in nessun paziente del gruppo placebo (Wharton et al., 2025)